课题基金 / 基金详情

Examining gaps in the viral hepatitis cascade of prevention and care for marginalized women

Examining gaps in the viral hepatitis cascade of prevention and care for marginalized women
检查边缘化妇女的病毒性肝炎预防和护理级联中的差距
批准号:
366567
负责人:
Goldenberg Shira
金额:
$7.29万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2016
资助国家:
加拿大
项目状态:
已结题
起止时间:
2016-11-01 至 2017-11-01

项目摘要

项目成果

Goldenberg Shira的其他基金

相似基金

相关文献

中文摘要
翻译
病毒性肝炎是全球导致死亡和残疾的主要原因。2016年,通过了第一批全球肝炎目标,促使这一目标成为研究和行动的优先事项。到目前为止,大多数病毒性肝炎研究都集中在丙型肝炎(丙型肝炎)。
英文摘要
Viral hepatitis is a leading cause of death and disability globally. In 2016, the first global hepatitis targets were adopted, galvanizing this as a priority for research and action. To date, most viral hepatitis research has focused on hepatitis C (HCV)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating Inequities in Refugee and Immigrant Women's Sexual and Reproductive Health Access (IRIS): A Mixed-Methods, Population-Based Study in British Columbia
Evaluating Impacts of Structural and Community-Led Interventions on STBBI Risk Environments for Street and Off-Street Sex Workers
Evaluating the impacts of migration and mobility on HIV, STIs and viral hepatitis among female sex workers in British Columbia
A research program on migration as a social determinant of HIV, STIs, & HCV among marginalized women
国内基金
海外基金
人类免疫缺陷病毒(HIV)总核酸检测试剂盒
HIV相关肺癌免疫微环境中关键免疫细胞亚群的功能特征与调控机制研究
基于深度测序与SNV 芯片的HIV重复感染与毒株重组机制研究
  • 批准号:
    2026JJ81281
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    徐艳
  • 依托单位:
PGT123中和抗体修饰的工程化载肽囊泡疫苗通过诱导CD4+ T细胞极化在抗HIV感染中的应用和机制研究